Neuraxpharm
ent_75245c4a3f8ba84316853641
Neuraxpharm is a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, including psychiatric and neurological conditions. The company develops and commercializes value-added medicines for patients with chronic CNS disorders.
AI-summarized from indexed web sources · Spain · 2026-08-04 · source
Disclosures
1
Leak Site · 1 jurisdiction
Multi-filing incidents
—
no multi-filing incident in sample
Max affected reported
—
no filed count in sample
Leak-site claims
1
unverified actor claims
Identity resolution
- Canonical name
- Neuraxpharm
- Normalized
- neuraxpharm— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- No match
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- neuraxpharm.com
Unverified threat-actor claim — not a regulatory filing
Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.